← Holders
Rosalind Advisors, Inc.
What Rosalind Advisors, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1622627 · Filed Nov 16, 2026
- Positions
- 46
- Reported value
- $311.9M
- Opened
- 15
- Closed
- 4
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$292.6M39 positions
- Dec 31, 2025$284.5M42 positions
- Mar 31, 2026$248.9M38 positions
- Jun 30, 2026$269.2M35 positions
- Sep 30, 2026$311.9M46 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
DCTHDelcath Systems, Inc. | 3.3M | ±0% | $52.7M | 16.9% |
VSTMVerastem, Inc. | 4.2M | +6.3% | $34.1M | 10.9% |
FENCFennec Pharmaceuticals Inc. | 3.2M | ±0% | $34M | 10.9% |
XERSXeris Biopharma Holdings, Inc. | 2.6M | −11.2% | $24.7M | 7.9% |
HELPHelus Pharma Inc. | 1.4M | −29.1% | $17.1M | 5.5% |
SVRASavara Inc | 3.2M | ±0% | $16.4M | 5.3% |
REPLReplimune Group, Inc. | 1M | New | $13.2M | 4.2% |
VORVor Biopharma Inc. | 609.2K | −6.1% | $11.6M | 3.7% |
MDWDMediWound Ltd. | 749.1K | ±0% | $10.3M | 3.3% |
XFORX4 Pharmaceuticals, Inc | 3.2M | ±0% | $9.3M | 3% |
AQSTAquestive Therapeutics, Inc. | 2M | +700.0% | $9.3M | 3% |
PCVXVaxcyte, Inc. | 149.4K | −25.3% | $8.5M | 2.7% |
TARAProtara Therapeutics, Inc. | 2.4M | New | $7.3M | 2.3% |
MYOMyomo, Inc. | 3.9M | +7.7% | $6.1M | 2% |
BCRXBiocryst Pharmaceuticals Inc | 721.5K | ±0% | $6M | 1.9% |
RCKTRocket Pharmaceuticals, Inc. | 2.2M | New | $5.8M | 1.9% |
PEPGPepGen Inc. | 2M | +471.4% | $4.8M | 1.6% |
PROFProfound Medical Corp. | 828.1K | ±0% | $4.8M | 1.5% |
TLPHTalphera, Inc. | 4.1M | −20.0% | $4.8M | 1.5% |
NRXSNeuraxis, INC | 548.1K | +7.9% | $4M | 1.3% |
OVIDOvid Therapeutics Inc. | 1.1M | ±0% | $2.8M | 0.9% |
NSPRInspireMD, Inc. | 3.9M | ±0% | $2.6M | 0.8% |
ABOSAcumen Pharmaceuticals, Inc. | 1.1M | New | $2.4M | 0.8% |
EYPTEyePoint, Inc. | 696K | −29.6% | $2.3M | 0.7% |
ABVXAbivax S.A. | 20.9K | ±0% | $2.1M | 0.7% |
BFRIBiofrontera Inc. | 1.8M | +40.3% | $1.9M | 0.6% |
FEMYFemasys Inc | 759.2K | New | $1.6M | 0.5% |
AVIRAtea Pharmaceuticals, Inc. | 280.1K | −73.8% | $1.5M | 0.5% |
CGONCG Oncology, Inc. | 20K | New | $1.4M | 0.5% |
SPRBSpruce Biosciences, Inc. | 26.5K | +32.6% | $1.3M | 0.4% |
RGNTRegentis Biomaterials Ltd. | 701.7K | ±0% | $1.3M | 0.4% |
KURAKura Oncology, Inc. | 100K | ±0% | $1.1M | 0.3% |
GRCEGrace Therapeutics, Inc. | 476.2K | New | $1M | 0.3% |
PYPDPolyPid Ltd. | 177K | −54.5% | $932.8K | 0.3% |
SPDR SERIES TRUSTPUTPut option | 250K | +77.8% | $925K | 0.3% |
STATE STR SPDR S&P 500 ETF TPUTPut option | 100K | New | $382K | 0.1% |
VERASTEM INCCALLCall option | 293.6K | New | $356.5K | 0.1% |
INVESCO QQQ TRPUTPut option | 50K | New | $257.5K | 0.1% |
PEPGEN INCCALLCall option | 412.7K | New | $256.9K | 0.1% |
OKUROnKure Therapeutics, Inc. | 67.5K | −55.0% | $184K | 0.1% |
XERIS BIOPHARMA HOLDINGS INCCALLCall option | 400K | New | $160K | 0.1% |
SELLAS LIFE SCIENCES GROUP INCPUTPut option | 618.8K | +8.8% | $127K | 0.1% |
BRISTOL-MYERS SQUIBB COCALLCall option | 20K | New | $84.2K | 0.1% |
EYEPOINT INCCALLCall option | 701.7K | +1,295.0% | $50K | 0.1% |
CORCEPT THERAPEUTICS INCPUTPut option | 10K | New | $23.5K | 0.1% |
CELLDEX THERAPEUTICS INCPUTPut option | 128.8K | New | $0 | 0% |